Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of β-chemokines

Journal of Infectious Diseases

Volumn 181, Issue 2, 2000, Pages 476-483

  Boyer, Jean D ^a   Cohen, Adam D ^a   Vogt, Suzanne ^a   Schumann, Kristen ^a   Nath, Brett ^a   Ahn, Lois ^a   Lacy, Kim ^b   Bagarazzi, Mark L ^c   Higgins, Terry J ^d   Baine, Yaela ^d   Ciccarelli, Richard B ^d   Ginsberg, Richard S ^d   MacGregor, Rob Roy ^b   Weiner, David B ^a,e  

^a Dept of Pathol/Laboratory Medicine ^*  (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d Wyeth Lederle Vaccines   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; DNA VACCINE; REV PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DOSE RESPONSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; VACCINATION;

AIDS VACCINES; CHEMOKINES, CC; GENES, ENV; GENES, REV; HIV SERONEGATIVITY; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA;

EID: 0034087642     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315229     Document Type: Article

References (33)

1. Letvin NL. Progress in the development of an HIV-1 vaccine. Science 1998;280:1875-80.
2. Burton DR, Moore JP. Why do we not have an HIV vaccine and how can we make one? Nat Med 1998;4(Suppl):495-8.
3. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996;271;324-8.
4. Rosenberg ES, Billings, JM Caliendo AM, et al. Vigorous HIV-1 specific CD4 T cell responses associated with control of viremia. Science 1997;278:1447-50.
5. Ahmed R, Butler LD, Bhatti T. CD4 T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J Virol 1988;62:2102-6.
6. Kalams SA, Walker B. The critical need for CD4 help in maintaining effective cytotoxic T lymphocytes responses. J Exp Med 1998;188:2199-204.
7. Dubensky T, Campell B, Villarreal L. Direct transfection of viral and plasmid DNA into the liver of spleen of mice. Proc Natl Acad Sci USA 1984;81:7529-33.
8. Raz E, Wantanabe A, Baird SM, et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci USA 1993;90:4523-7.
9. Tang DC, Devit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992;356:152-4.
10. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-8.
11. Ulmer JB, Donnelly J, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745-9.
12. Wang B, Ugen KE, Srikantan V, et al. Geneunoculation generates immune response against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993;90:4156-60.
13. Michel ML, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen R. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 1995;92:5307-11.
14. Lowrie DB, Tascon RE, Colston MJ, Silva CL. Towards a DNA vaccine against tuberculosis. Vaccine 1994;12:1537-40.
15. Wang B, Boyer J, Srikantan V, et al. Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in non-human primates by in vivo DNA inoculation. Virology 1995;211:102-12.
16. Letvin NL, Montefiori DC, Yasutomi Y, et al. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA 1997;94:9378-83.
17. Liu MA, McClements W, Ulmer JB, Shiver J, Donnelly J. Immunization of non-human primates with DNA vaccines. Vaccine 1997;15:909-12.
18. Lu S, Arthos J, Montefiori DC, et al. Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol 1996;70:3978-91.
19. Fuller DH, Simpson L, Cole KS, et al. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol Cell Biol 1997;75:389-96.
20. Boyer JD, Ugen KE, Wang B, et al. Induction of a Th1 type cellular immune responses to human immunodeficiency type 1 virus by in vivo DNA inoculation. Modulation of the Immune Response to Vaccine Antigens. Dev Biol Stand 1998;92:169-74.
21. Boyer J, Ugen K, Wang B, et al. Induction of protective humoral and cellular immune responses to HIV-1 in chimpanzees by in vivo DNA inoculation. Nat Med 1997;3:526-32.
22. MacGregor RR, Boyer JD, Ugen KE, et al. First human trial of a DNA-based vaccine for the treatment of human immunodeficiency virus type 1 infection: safety and host responses. J Infect Dis 1998;178:92-100.
23. Cooney EL, McElrath MJ, Corey L, et al. Enhanced immunity to human immunodeficiency virus, envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein, Proc Natl Acad Sci USA 1993;90:1882-6.
24. Ferrari G, Humphrey W, McElrath MJ, et al. Clade B based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocytes reactivities in uninfected volunteers. Proc Natl Acad Sci USA 1997;94:1396-1401.
25. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-6.
26. Mackewicz CE, Ortega HW, Levy JA. CD8 activity correlates with the clinical state of the infected individual. J Clin Invest 1991;87:1462-6.
27. + T cell. Science 1995;270:1811-5.
28. Alkhatib G, Locati M, Kennedy PE, Murphy PM, Berger EA. HIV-1 co-receptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology 1997;234:340-8.
29. Heeney JL, Teeuwsen VJ, van Gils M, et al. Beta-chemokines and neutralizing antibodies correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proc Natl Acad Sci USA 1998;95:10803-8.
30. Calarota S, Bratt G, Nordlund S, et al. Cellular cytotoxic response induced by DNA vaccination in HIV-1 infected patients. Lancet 1998;351:1320-5.
31. Boyer JD, Chattergoon MA, Ugen KW, et al. Enhancement of cellular immune response in HIV-1 seropositive individuals: a DNA-based trial. Clin Immunol 1999;90:100-7.
32. Wang R, Doolan DL, Le TP, et al. Induction of antigen-specific cytotoxic t lymphocytes in humans by a malaria DNA vaccine. Science 1998;282:476-9.
33. Cohen A, Boyer JD, Weiner DB. Modulating the immune response to genetic immunization. FASEB J 1998;12:1611-26.